Take Solutions Limited Stock Analysis
Take Solutions Limited (TAKE) is a India-based company listed on NSE. This AI-powered analysis provides investment insights based on quarterly earnings reports and financial performance metrics.
Overall verdict for a 6-12 month horizon is Sell, because reported profitability appears non-core and is overshadowed by serious balance-sheet and going-concern risks. In Q3 FY2025-26, PAT was Rs. 110.96 lakhs on total income of Rs. 146.14 lakhs, but this income was reported as entirely other income in management commentary, indicating weak earnings quality despite EPS of Rs. 0.08. Cost control was visible with total expenses at Rs. 35.18 lakhs (employee cost Rs. 13.53 lakhs, finance cost Rs. 0.06 lakhs), yet auditors maintained a qualified opinion and highlighted material uncertainties. The risk stack remains heavy: prior-year loss of Rs. 6,973.6 lakhs, direct tax litigations of Rs. 1,080.3 lakhs, and questionable recoverability of deferred tax assets (Rs. 883.2 lakhs) and indirect tax credits (Rs. 516.4 lakhs), along with unpaid statutory dues.
AI Investment Score & Analysis
+ Key Strengths
- Key Risks
Forward Outlook
This quarter’s key strategic context is post-divestment repositioning: after exiting Ecron Acunova, management is pursuing diversification outside CRO due to non-compete constraints. The stated forward plan is to close strategic partnerships, mergers, and acquisitions through non-cash transactions in FY2026, but management itself indicates outcomes and financial impact are still uncertain. For the next 2-4 quarters, the main catalysts are concrete closure and execution of these diversification deals rather than organic operating momentum. Current momentum appears decelerated in core operations because business commentary highlights severely impacted operations and no dependable operating revenue base. Until new initiatives convert into recurring revenue and governance overhangs reduce, near-term performance is likely to remain volatile and event-driven.
Detailed AI Analysis by Provider
Overall verdict for a 6-12 month horizon is Sell, because reported profitability appears non-core and is overshadowed by serious balance-sheet and going-concern risks. In Q3 FY2025-26, PAT was Rs. 110.96 lakhs on total income of Rs. 146.14 lakhs, but this income was reported as entirely other income in management commentary, indicating weak earnings quality despite EPS of Rs. 0.08. Cost control was visible with total expenses at Rs. 35.18 lakhs (employee cost Rs. 13.53 lakhs, finance cost Rs. 0.06 lakhs), yet auditors maintained a qualified opinion and highlighted material uncertainties. The risk stack remains heavy: prior-year loss of Rs. 6,973.6 lakhs, direct tax litigations of Rs. 1,080.3 lakhs, and questionable recoverability of deferred tax assets (Rs. 883.2 lakhs) and indirect tax credits (Rs. 516.4 lakhs), along with unpaid statutory dues.
Forward Outlook
This quarter’s key strategic context is post-divestment repositioning: after exiting Ecron Acunova, management is pursuing diversification outside CRO due to non-compete constraints. The stated forward plan is to close strategic partnerships, mergers, and acquisitions through non-cash transactions in FY2026, but management itself indicates outcomes and financial impact are still uncertain. For the next 2-4 quarters, the main catalysts are concrete closure and execution of these diversification deals rather than organic operating momentum. Current momentum appears decelerated in core operations because business commentary highlights severely impacted operations and no dependable operating revenue base. Until new initiatives convert into recurring revenue and governance overhangs reduce, near-term performance is likely to remain volatile and event-driven.
Strengths
Risks
TAKE Solutions exhibits severe financial distress with zero operational revenue (Rs. 0 lakhs from operations in Q3 FY2025-26) and complete reliance on other income of Rs. 146.14 lakhs to report a nominal profit of Rs. 110.96 lakhs. The company received a qualified audit opinion citing material going concern uncertainties including a massive loss of Rs. 6,973.6 lakhs in FY2024-25, substantial networth erosion, contingent tax liabilities of Rs. 1,080.3 lakhs, and questionable recoverability of deferred tax assets worth Rs. 883.2 lakhs. After divesting its core CRO subsidiary Ecron Acunova Limited in FY2024-25, the company is bound by non-compete obligations that prevent it from operating in its historical industry, leaving it essentially a shell entity with no business model. Management's diversification plans for FY2026 remain entirely speculative with uncertain outcomes, and unpaid statutory dues combined with severely impaired asset values raise serious questions about survival beyond the near term.
Forward Outlook
The company has no operating business following the FY2024-25 divestment of its CRO subsidiary and is constrained by non-compete obligations from re-entering that industry. Management has initiated discussions for diversification into other verticals and potential strategic partnerships, mergers, or acquisitions structured as non-cash transactions, with expectations of positive closure during FY2026, but these remain speculative with no binding commitments or disclosed sectors of interest. The Q3 profit of Rs. 110.96 lakhs was entirely driven by other income rather than operational performance, and with zero revenue from operations, no demonstrated business model, qualified audit opinion on going concern, and over Rs. 2,480 lakhs in disputed tax liabilities with questionable asset recoverability, the company faces existential risk. Investors should expect continued uncertainty and potential inability to sustain operations unless concrete diversification deals materialize and generate sustainable revenue within the next 2-3 quarters.
Strengths
Risks
Score History
Score Timeline
All Scores
| Date | Report | Score | Sentiment | AI | |
|---|---|---|---|---|---|
| Mar 6, 2026 | Take Solutions Limited - Financial Results (15/2/2026) | 3.5 | Sell | ChatGPT | |
| Feb 28, 2026 | Take Solutions Limited - Financial Results (15/2/2026) | 2.0 | Strong Sell | Claude |
Related Stocks on NSE
Frequently Asked Questions
What is the AI Stock Score?
The AI Stock Score is a composite rating from 0-10 generated by analyzing quarterly earnings reports using three leading AI models (Google Gemini, Anthropic Claude, and OpenAI ChatGPT). Each AI independently evaluates financial performance, growth prospects, risks, and market positioning to provide an objective investment perspective.
How should I interpret Buy/Hold/Sell ratings?
Buy (7.0-10.0): Strong fundamentals and positive outlook. Hold (4.0-6.9): Mixed signals, suitable for existing positions. Sell (0-3.9): Deteriorating fundamentals or significant risks. These are AI-generated opinions for informational purposes only, not investment advice.
How is the composite score calculated?
The composite score is the mathematical average of the latest scores from each AI provider. For example, if Gemini rates 7.5, Claude rates 4.5, and ChatGPT rates 6.0, the composite score would be (7.5+4.5+6.0)/3 = 6.0. This multi-AI approach reduces bias from any single model.
How often are scores updated?
Scores are automatically generated within hours of quarterly earnings results being published on NSE. The system monitors earnings announcements 4 times daily and processes new reports immediately. Check the "Last Updated" date at the top of this page for the most recent analysis timestamp.
Is this financial advice?
No. This is AI-generated analysis for informational and educational purposes only. MarketsHost is not a SEBI-registered Research Analyst or Investment Adviser. AI models can produce inaccurate results. Always consult a qualified financial advisor and conduct your own due diligence before making investment decisions.